Unitedhealth Group Inc (NYSE:UNH) does about 4.45M shares in volume on a normal day but saw 5370484 shares change hands in Monday trading. The company now has a market cap of 410.84B USD. Its current market price is $445.63, marking an increase of 1.46% compared to the previous close of $439.20. The 52 week high reached by this stock is $554.70 whilst the lowest price level in 52 weeks is $436.38.
Unitedhealth Group Inc (UNH) has a 20-day trading average at $471.67 and the current price is -19.66% off the 52-week high compared with 2.12% distance from its 52-week low. The 50-day simple moving average of the closing price is $491.10 and its 200-day simple moving average is $507.92. If we look at the stock’s price movements over the week, volatility stands at 1.70%, which decreases to 1.49% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 30.36 to suggest the stock is neutral.
The consensus objective for the share price is $577.90, suggesting that the stock has a potential upside of 22.89% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on April 04, 2024 when HSBC Securities upgraded the stock to “Hold” and issued a price target of $460. HSBC Securities downgraded its price target at $550-$480.
Unitedhealth Group Inc (UNH) stock is down -2.27% over the week and -8.87% over the past month. Its price is -15.36% year-to-date and -15.32% over the past year.
The stock last released its quarterly earnings report for quarter ended 12/31/2023, with the company’s earnings per share (EPS) of $5.68 above consensus estimates by $0.17. UNH’s earnings per share are forecast to grow by 18.90% this year and 13.00% over next year. Expected sales for next quarter are $99.64 billion, which analysts say will come at $400.24 billion for the current fiscal year and next year at $430.84 billion. In addition, estimates put the company’s current quarterly revenue at an average of $99.29 billion.
To reach the target analysts have set, the stock logically needs to grow 22.89 percent from here.
The company has a return on investment of 14.83% and return on equity of 26.88%. The price to earnings ratio (P/E ratio) amounts to 18.69 while the forward price to earnings ratio is 14.34. The beta has a value of 0.58. Price to book ratio is 4.64 and price to sales ratio is 1.11.
